Vanguard S&P 500 ETF (VOO) Stock Price Today
Aura AI Summary
Key Stats
- $1.80TMarket Cap
- 5,448,010Volume
- Broad Market / FactorSector
- $714.9052W High
- $580.9352W Low
- 55 DaysTypical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track Vanguard S&P 500 ETF (VOO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Vanguard S&P 500 ETF has traded between a low of $580.93 and a high of $714.9, highlighting its annual price range. Buy and sell Vanguard S&P 500 ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Vanguard S&P 500 ETF
VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.
Most Recent News
First Hydrogen completes unmanned ground vehicle, gains exclusive global patent rights.
First Hydrogen Corp. has successfully built its unmanned ground vehicle (UGV), achieving a key development milestone and securing exclusive worldwide rights to the related patented technology for the patent's remaining life, with a 1% royalty on sale...

Coiled Therapeutics expects first safety data for new AO-252 cancer drug formulation by end of 2026
Coiled Therapeutics plans to report initial safety and pharmacokinetic data for its new AO-252 cancer drug formulation by the end of 2026 after dosing up to 30 patients. The new lipid-based softgel aims to improve drug absorption and consistency, wit...

Poolbeg Pharma doses 8 patients in trial to prevent cancer immunotherapy side effect CRS
Poolbeg Pharma has dosed eight patients in its TOPICAL trial testing POLB 001 to prevent cytokine release syndrome (CRS), a dangerous immune reaction caused by cancer immunotherapy. The trial targets multiple myeloma patients receiving teclistamab, a...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.